Correlation between Surgical Outcome and Stage of Acquired Middle Ear Cholesteatoma: Revalidation of the EAONO/JOS Staging System

Abstract

The Journal of International Advanced Otology (J Int Adv Otol) is an international, peer reviewed, open access publication that is fully sponsored and owned by the European Academy of Otology and Neurotology and the Politzer Society. The journal is published triannually in April, August, and December and its publication language is English. The scope of the Journal is limited with otology, neurotology, audiology (excluding linguistics) and skull base medicine. The Journal of International Advanced Otology aims to publish manuscripts at the highest clinical and scientific level. J Int Adv Otol publishes original articles in the form of clinical and basic research, review articles, short reports and a limited number of case reports. Controversial patient discussions, communications on emerging technology, and historical issues will also be considered for publication. Target audience of J Int Adv Otol includes physicians and academics who work in the fields of otology, neurotology, audiology and skull base medicine.

Long-term follow-up of applying autologous bone grafts for reconstructing tympanomastoid defects in functional cholesteatoma surgery

“…Early-stage cholesteatoma and pars flaccida cholesteatoma were determined to be independent predictors of hearing success in the multivariate analysis. This finding is consistent with that of a study conducted in 2020 by Ardic et al (2020) . The authors evaluated the surgical outcomes of cholesteatoma surgery and correlated them with the classifications of the newly proposed EAONO/JOS staging system.…”

Correlation between functional outcome and the SAMEO-ATO framework

“…The authors showed that the recidivism rate was higher in children, in case of larger bone canal defect or cholesteatoma located in the supra-tubal recess; however, the prognostic role of the classification was defined as "uncertain" [13]. Ardıç et al [14] correlated the surgical outcomes with the EAONO/JOS staging system and reported no correlation between the staging system and the recurrence rate.…”

New classification of EAONO/JOS cholesteatoma and SAMEO-ATO middle ear surgery: relevance and clinical significance

“…(2020 г. ), получены данные о большей частоте встречаемости пациентов с III стадией заболевания (31%), при этом доля пациентов с I и II стадиями составила соответственно 39 и 28%, с IV стадией -2% [8].…”

“…Хирургическое лечение направлено на полное удаление патологического процесса с целью предотвращения развития осложнений и улучшения слуха. Ведущей проблемой хирургического лечения ХСУ является высокая частота рецидивирования, составляющая от 5 до 32% в зависимости от различных типов хирургического лечения [7,8].…”

“…В последние годы активно разрабатываются различные системы классификации и стадирования холестеатомы [8]. Авторы пришли к выводу, что данные системы могут быть использованы для определения риска рецидивирования и прогноза в отношении восстановления слуха после операций, а также для корректного сравнения результатов клинических исследований с применением различных типов хирургических вмешательств.…”